Full Fed. Circ. Rejects Sanofi's Bid To Expand Arthrex To All
The full Federal Circuit on Tuesday shot down Sanofi-Aventis' request to make a panel's recent decision finding the Patent Trial and Appeal Board's structure unconstitutional apply to companies that didn't raise...To view the full article, register now.
Already a subscriber? Click here to view full article